I’m playing catch-up on some reading given how busy I’ve been and this includes a groundbreaking NEJM pub on CRISPR for Sickle Cell and Thalassemia. CRISPR for Sickle Cell From December, here’s the key paper in the NEJM: CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. There’s a lot to like about this clinical …

Recommended reads: CRISPR for Sickle Cell, Parkinson’s, & more Read More »

The post Recommended reads: CRISPR for Sickle Cell, Parkinson’s, & more appeared first on The Niche.

Read Original